Amikacin Impurity 7

Basic Information

View in Editor

CAS Number

34368-52-0

Molecular Formula

C4H7NO2

Molecular Weight

101.1 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Water Treatment Chemicals Coagulants and Flocculants Inorganic Coagulants

Basic Physical Properties

Physical State

White to Yellow Solid

Melting Point

No data available

Boiling Point

363.6°C at 760 mmHg

Density

1.3±0.1 g/cm3

Flash Point

173.7±25.9 °C

Refractive Index

1.513

SMILES

View in Editor

C1CNC(=O)C1O

InChI

InChI=1S/C4H7NO2/c6-3-1-2-5-4(3)7/h3,6H,1-2H2,(H,5,7)/t3-/m0/s1

InChIKey

FRKGSNOMLIYPSH-VKHMYHEASA-N

LogP

-1.1328

Topological Polar Surface Area

49.33 Å²

Hydrogen Bond Donor/Acceptor

2 / 3

Complexity

91.7

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

DTXSID50955910
AS-81159
(3s)-3-hydroxy-2-pyrrolidinone
(S)-3-hydroxy-pyrrolidin-2-one, AldrichCPR
Q-103501
MFCD06796625
FRKGSNOMLIYPSH-VKHMYHEASA-N
PS-9317
(S)-3-Hydroxypyrrolidin-2-one
3,4-Dihydro-2H-pyrrole-4,5-diol
BCP23403
(s)-(-)-3-hydroxy-2-pyrrolidone
(S)-3-HYDROXY-2-PYRROLIDINONE
(s)-(-)-3-hydroxy-2-pyrrolidinone
AC-24360
RKL10144
AKOS006346239
(S)-3-Hydroxypyrrolidine-2-one
(S)-3-Hydroxy-pyrrolidin-2-one
2-PYRROLIDINONE, 3-HYDROXY-, (3S)-
AKOS015855222
EN300-108390
AM20090532
CS-W003342
(S)-3-Hydroxy-2-pyrrolidone
34368-52-0
(5)-3-hydroxypyrrolidin-2-one
(3S)-3-hydroxypyrrolidin-2-one
SCHEMBL121281
(S)-3-hydroxy-pyrollidin-2-one
3(S)-hydroxy-pyrrolidin-2-one

MDL Number

MFCD06796625

Customs Code

2933790090

FAQ

What regulatory guidelines apply to Amikacin Impurity 7 (CAS: 34368-52-0)?

Regulatory guidelines for Amikacin Impurity 7 (CAS: 34368-52-0) include GHS classification for hazardous chemicals, REACH regulations for placing chemicals on the European market, and FDA/EPA requirements for drug and environmental safety. Compliance with these guidelines is crucial for manufacturing, handling, and disposal of the compound.

Are there alternatives to Amikacin Impurity 7 in synthesis (CAS: 34368-52-0)?

In synthesis, Amikacin Impurity 7 (CAS: 34368-52-0) can be replaced with similar impurities or by optimizing the reaction conditions to reduce impurities formation. Common alternatives include isomers or analogs with similar chemical structures, and using more selective reagents to achieve a higher purity product.

What is the market or research trend for Amikacin Impurity 7 (CAS: 34368-52-0)?

The market trend for Amikacin Impurity 7 (CAS: 34368-52-0) reflects a growing emphasis on drug purity and safety. Research is focusing on developing more effective and selective synthesis methods to minimize impurities, as well as on understanding the biological impact of these impurities to ensure compliance with regulatory standards.

How should waste containing Amikacin Impurity 7 (CAS: 34368-52-0) be handled?

Waste containing Amikacin Impurity 7 (CAS: 34368-52-0) should be collected in appropriate containers and stored in a secure, well-ventilated area. Proper incineration or professional waste disposal services should be used to ensure safe disposal. Environmental protection measures include minimizing exposure and preventing runoff, adhering to local regulations for hazardous waste management.